NO20063881L - Behandling av rhinitt med antikolinergier alene i kombinasjon med antihistaminer fosfodiesterase 4 inhibitorer eller kortikosteroider - Google Patents

Behandling av rhinitt med antikolinergier alene i kombinasjon med antihistaminer fosfodiesterase 4 inhibitorer eller kortikosteroider

Info

Publication number
NO20063881L
NO20063881L NO20063881A NO20063881A NO20063881L NO 20063881 L NO20063881 L NO 20063881L NO 20063881 A NO20063881 A NO 20063881A NO 20063881 A NO20063881 A NO 20063881A NO 20063881 L NO20063881 L NO 20063881L
Authority
NO
Norway
Prior art keywords
rhinitis
inhibitors
treatment
corticosteroids
combination
Prior art date
Application number
NO20063881A
Other languages
English (en)
Inventor
Istvan Szelenyi
Joachim Maus
Ursula Petzold
Torsten Hoffmann
Mario Weingart
Original Assignee
Meda Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Pharma Gmbh & Co Kg filed Critical Meda Pharma Gmbh & Co Kg
Publication of NO20063881L publication Critical patent/NO20063881L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Den foreliggende oppfinnelsen tilveiebringer nye kombinasjoner som omfatter et lokalt antikolinergisk medikament alene eller i kombinasjon med lokalt administrerte antihistaminer, lokalt eller oralt administrerte fosfordiesterase 4 inhibitorer eller lokale kortikosteroider for behandlingen av rinitt av ulik opprinnelse. Den omfatter ytterligere presentasjonen av disse kombinasjonene i lokale anvendte formuleringer og inkluderer ulike farmasøytiske formuleringer egnet for lokal anvendelse, for eksempel nesesprayer, nesedråper, emulsjoner, pasta, kremer og geleer.
NO20063881A 2004-02-06 2006-08-31 Behandling av rhinitt med antikolinergier alene i kombinasjon med antihistaminer fosfodiesterase 4 inhibitorer eller kortikosteroider NO20063881L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54195004P 2004-02-06 2004-02-06
PCT/EP2005/000653 WO2005074983A2 (en) 2004-02-06 2005-01-24 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids

Publications (1)

Publication Number Publication Date
NO20063881L true NO20063881L (no) 2006-11-02

Family

ID=34837531

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063881A NO20063881L (no) 2004-02-06 2006-08-31 Behandling av rhinitt med antikolinergier alene i kombinasjon med antihistaminer fosfodiesterase 4 inhibitorer eller kortikosteroider

Country Status (9)

Country Link
US (1) US20050222102A1 (no)
EP (1) EP1713472A2 (no)
JP (1) JP2007520509A (no)
CN (1) CN1913882A (no)
AU (1) AU2005210086A1 (no)
CA (1) CA2552458A1 (no)
NO (1) NO20063881L (no)
RU (1) RU2006132043A (no)
WO (1) WO2005074983A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1616567A1 (en) * 2004-07-16 2006-01-18 Boehringer Ingelheim Pharma GmbH & Co.KG Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts
GB0523653D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523655D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
ES2389231T3 (es) * 2005-12-21 2012-10-24 Meda Pharma Gmbh & Co. Kg Combinación de anticolinérgicos, glucocorticoides y agonistas de beta2 para el tratamiento de enfermedades inflamatorias
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US8815890B2 (en) * 2006-09-06 2014-08-26 Robert E. Weinstein Rhinitis treatment regimens
JP5208473B2 (ja) * 2006-10-06 2013-06-12 第一三共ヘルスケア株式会社 アゼラスチンと抗コリン薬を含有する医薬組成物
US20090117209A1 (en) * 2007-11-02 2009-05-07 Hutchison Medipharma Enterprises Limited Andrographis paniculata extract
BR112015023328A2 (pt) 2013-03-13 2017-07-18 Flatley Discovery Lab compostos de piridazinona e métodos para o tratamento de fibrose cística
CN104586841A (zh) * 2013-10-30 2015-05-06 中国药科大学 (3r,2’r)-格隆溴铵作为m3毒蕈碱性受体拮抗剂在制药中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501893A (en) * 1982-02-04 1985-02-26 Findlay John W A 3-{6-[3-Pyrrolidino-1-(4-tolyl)prop-1-enyl]-2-pyridyl}acrylic acid and pharmaceutically acceptable salts thereof
DE3877904D1 (de) * 1987-11-13 1993-03-11 Asta Pharma Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
WO1998000016A1 (en) * 1996-07-01 1998-01-08 Sepracor, Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate
SE9804000D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New composition of matter
US6086914A (en) * 1999-03-12 2000-07-11 Weinstein; Robert E. Nonsedating formulations for allergic rhinitis which possess antihistaminic and anticholinergic activity
US20020006961A1 (en) * 1999-05-14 2002-01-17 Katz Stanley E. Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
MY123585A (en) * 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
US20030216423A1 (en) * 2000-05-24 2003-11-20 Sergio Ulloa Stable liquid and solid formulations
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
EP1395288A1 (en) * 2001-05-25 2004-03-10 Pfizer Inc. A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases
ATE347361T1 (de) * 2001-05-25 2006-12-15 Boehringer Ingelheim Pharma Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
PL208686B1 (pl) * 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations

Also Published As

Publication number Publication date
EP1713472A2 (en) 2006-10-25
WO2005074983A2 (en) 2005-08-18
US20050222102A1 (en) 2005-10-06
AU2005210086A1 (en) 2005-08-18
CN1913882A (zh) 2007-02-14
RU2006132043A (ru) 2008-03-20
JP2007520509A (ja) 2007-07-26
CA2552458A1 (en) 2005-08-18
WO2005074983A3 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
NO20063881L (no) Behandling av rhinitt med antikolinergier alene i kombinasjon med antihistaminer fosfodiesterase 4 inhibitorer eller kortikosteroider
BRPI0517481A (pt) método para tratar, controlar ou evitar uma doença ou distúrbio parasìtico protozoário, e, composição farmacêutica
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
NO20072322L (no) Laktamforbindelser og anvendelse derav som farmasoytiske midler
NO20070372L (no) Amidoforbindelser og anvendelse derav som farmasoytiske preparater
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
NO20071048L (no) Amidoforbindelser og deres anvendelse som farmasoytika
WO2003094836A3 (en) Methods and products for enhancing immune responses using imidazoquinoline compounds
NO20064584L (no) Tetrahydropyridoindolderivater
NO20065442L (no) Amidoforbindelser og deres anvendelse som legemidler
TW200615266A (en) Organic compounds
NO20072599L (no) Inhibitorer av 11-beta-hydroksyl steroid dehydrogenase Type 1 og fremgangsmater for anvendelse derav
ECSP055738A (es) PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
BRPI0409884A (pt) compostos, composições farmacêuticas, método para o tratamento ou porfilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BRPI0409818A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BR0311866A (pt) Composições de saponinas ou sapogeninas para terapia de câncer
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
DK1343472T3 (da) Thixotropisk næsespray
NO323466B1 (no) Nye kinolinyl-piperidin-4-yliden-metyl-benzamidderivater, fremgangsmate til fremstilling derav, anvendelse derav i medikamenter til behandling av smerte, samt farmasoytisk sammensetning som innbefatter slike derivater
WO2004085436A3 (en) Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2003066806A3 (en) Therapeutic use of aziridino compounds
BRPI0417003A (pt) uso de derivados de ácido pentadienóico para o tratamento de hiperuricemia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application